Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers

European Journal of Cancer

Volumn 42, Issue 5, 2006, Pages 650-655

  Sade, Revital Bruchim Bar ^a   Chetrit, Angela ^a   Figer, Arie ^c   Papa, Moshe Z ^b   Flex, Dov ^d,e   Rizel, Shulamit ^d,e   Friedman, Eitan ^a  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

BRCA1 2 germline mutations; Breast cancer; HRT and OC use; Reproductive factors

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PATIENT; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HETEROZYGOTE; HORMONE SUBSTITUTION; HUMAN; ISRAEL; JEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENARCHE; MULTIVARIATE ANALYSIS; MUTATIONAL ANALYSIS; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; REPRODUCTION;

ADULT; AGED; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; GENES, BRCA1; GENES, BRCA2; HETEROZYGOTE; HORMONE REPLACEMENT THERAPY; HUMANS; JEWS; MIDDLE AGED; MUTATION; REGRESSION ANALYSIS;

EID: 33644780764     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.08.045     Document Type: Article

References (50)

1. A. Jemal, A. Thomas, and T. Murray Cancer statistics, 2002 CA Cancer J Clin 52 2002 23 47
2. T.J. Key, P.K. Verkasalo, and E. Banks Epidemiology of breast cancer Lancet Oncol 2 3 2001 133 140
3. D.F. Easton, D.T. Bishop, and D. Ford Genetic linkage analysis in familial breast and ovarian cancer Am J Hum Genet 52 1993 718 722
4. C.I. Szabo, and M.C. King Inherited breast and ovarian cancer Hum Mol Genet 4 1995 1811 1817
5. K.M. Egan, M.J. Stampfer, and B.A. Rosner Risk factors for breast cancer in women with a breast cancer family history Cancer Epidemiol Biomarkers Prev 7 1998 359 364
6. D. Ford, D.F. Easton, and D.T. Bishop Risks of cancer in BRCA1 mutation carriers Lancet 343 1994 692 695
7. D. Ford, D.F. Easton, and M. Stratton Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 1998 676 689
8. D. Abeliovich, L. Kaduri, and I. Lerer The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women Am J Hum Genet 60 1997 505 514
9. C.I. Szabo, and M.C. King Population genetics of BRCA1 and BRCA2 Am J Hum Genet 60 1997 1013 1020
10. R. Shiri-Sverdlov, P. Oefner, and L. Green Mutational analysis of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast cancer Hum Mutat 6 2000 491 501
11. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Lancet 347 9017 1996 1713 1727
12. D.M. Grabrick, L.C. Hartmann, and J.R. Cerhan Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer JAMA 284 2000 1791 1798
13. G. Ursin, B.E. Henderson, and R.W. Haile Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 57 1997 3678 3681
14. S.A. Narod Hormonal prevention of hereditary breast cancer Ann NY Acad Sci 952 2001 36 43
15. S.M. Gapstur, M. Morrow, and T.A. Sellers Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study JAMA 281 1999 2091 2097
16. L.K. Weiss, R.T. Burkman, and K.L. Cushing-Haugen Hormone replacement therapy regimens and breast cancer risk Obstet Gynecol 100 2002 1148 1158
17. H.D. Nelson, L.L. Humphrey, and P. Nygren Postmenopausal hormone replacement therapy: scientific review JAMA 288 2002 872 881
18. H.C. Jernstrom, O.T. Johannsson, and N. Loman Reproductive factors in hereditary breast cancer Breast Cancer Res Treat 58 1999 295 301
19. H. Jernstrom, C. Lerman, and P. Ghadirian Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2 Lancet 354 9193 1999 1846 1850
20. S.A. Narod, M.P. Dube, and J. Klijn Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers J Natl Cancer Inst 94 2002 1773 1779
21. H.T. Lynch, P. Watson, and S. Tinley An update on DNA-based BRCA1/BRCA2 genetic counselling in hereditary breast cancer Cancer Genet Cytogenet 109 1999 91 98
22. E.M. Rohlf, W.G. Learning, and K.J. Friedman Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis Clin Chem 43 1997 24 29
23. W.W. Piegorsch, C.R. Weinberg, and J.A. Taylor Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies Stat Med 13 1994 153 162
24. E. Warner, W. Foulkes, and P. Goodwin Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer J Natl Cancer Inst 91 1999 1241 1247
25. G. Johannesdottir, J. Gudmundsson, and J.T. Bergthorsson High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients Cancer Res 56 1996 3663 3665
26. S. Thorlacius, J.P. Struewing, and P. Hartge Population-based study of risk of breast cancer in carriers of BRCA2 mutation Lancet 352 9137 1998 1337 1339
27. K. Syrjakoski, P. Vahteristo, and H. Eerola Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients J Natl Cancer Inst 92 2000 1529 1531
28. H. Anton-Culver, P.F. Cohen, and M.E. Gildea Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer Eur J Cancer 36 2000 1200 1208
29. H.A. Shih, F.J. Couch, and K.L. Nathanson BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic J Clin Oncol 20 2002 994 999
30. T.S. Frank, A.M. Deffenbaugh, and J.E. Reid Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals J Clin Oncol 20 2002 1480 1490
31. H. Olsson, A. Bladstrom, and C. Ingvar A population-based cohort study of HRT use and breast cancer in southern Sweden Br J Cancer 85 2001 674 677
32. B. De Lignieres, F. De Vathaire, and S. Fournier Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women Climacteric 5 2002 332 340
33. I.S. Fentiman How do endogenous oestrogens affect breast cancer? Eur J Cancer 38 Suppl. 6 2002 S59 S60
34. R.T. Chlebowski, S.L. Hendrix, and R.D. Langer Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 2003 3243 3253
35. V. Beral Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 9382 2003 419 427
36. K.H. Humphries, and S. Gill Risks and benefits of hormone replacement therapy: The evidence speaks CMAJ 168 2003 1001 1010
37. S.R. Lakhani, J.S. Reis-Filho, and L. Fulford Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 14 2005 5175 5180
38. M. Ewertz Oral contraceptives and breast cancer risk in Denmark Eur J Cancer 28A 6-7 1992 1176 1181
39. C. La Vecchia, A. Altieri, and S. Franceschi Oral contraceptives and cancer: an update Drug Saf 24 2001 741 754
40. G. Ursin, R.K. Ross, and J. Sullivan-Halley Use of oral contraceptives and risk of breast cancer in young women Breast Cancer Res Treat 50 1998 175 184
41. K. Heimdal, E. Skovlund, and P. Moller Oral contraceptives and risk of familial breast cancer Cancer Detect Prev 26 2002 23 27
42. P.A. Marchbanks, J.A. McDonald, and H.G. Wilson Oral contraceptives and the risk of breast cancer N Engl J Med 346 2002 2025 2032
43. L. Kaduri, M. Gibs, and A. Hubert Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers Eur J Obstet Gynecol Reprod Biol 85 1999 75 80
44. R. Talamini, S. Franceschi, and C. La Vecchia The role of reproductive and menstrual factors in cancer of the breast before and after menopause Eur J Cancer 32A 2 1996 303 310
45. N. Andrieu, T. Prevost, and T.E. Rohan Variation in the interaction between familial and reproductive factors on the risk of breast cancer according to age, menopausal status, and degree of familiality Int J Epidemiol 29 2002 214 223
46. F. Clavel-Chapelon E3N-EPIC Group Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women Br J Cancer 86 2002 723 727
47. D.M. Grabrick, R.A. Vierkant, and K.E. Anderson Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States) Cancer Causes Control 13 2002 333 341
48. J. Chang-Claude, H. Becher, and N. Eby Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers J Cancer Res Clin Oncol 123 1997 272 279
49. P. Hartge, N. Chatterjee, and S. Wacholder Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history Epidemiology 13 2002 255 261
50. L. Tryggvadottir, E.J. Olafsdottir, and S. Gudlaugsdottir BRCA2 mutation carriers, reproductive factors and breast cancer risk Breast Cancer Res 5 2003 R121 R128